2024-08 |
EUS-guided FNA and biopsy for cytohistologic diagnosis of gallbladder cancer: a multicenter retrospective study |
Gastrointestinal Endoscopy
|
2024-03 |
Transgelin-2, a novel cancer stem cell-related biomarker, is a diagnostic and therapeutic target for biliary tract cancer |
BMC Cancer
|
2024-02 |
Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer |
Scientific Reports
|
2024-01 |
Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis |
Genome Medicine
|
2024-01 |
Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy |
Cancer Research and Treatment
|
2024-01 |
Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction |
American Journal of Gastroenterology
|
2024-01 |
Comparison of Physician-Controlled Maneuver and Assistant-Controlled Maneuver during Endoscopic Retrograde Cholangiopancreatography |
Yonsei Medical Journal
|
2023-11 |
The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer |
Gut and Liver
|
2023-11 |
Factors Influencing the Diagnostic Performance of Repeat Endoscopic Ultrasound-Guided Fine-Needle Aspiration/Biopsy after the First Inconclusive Diagnosis of Pancreatic Solid Lesions |
Gut and Liver
|
2023-10 |
DEMA: Robotic dual-electromagnet actuation system integrated with localization for a magnetic capsule endoscope |
Sensors and Actuators A: Physical
|
2023-09 |
Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study |
Frontiers in Oncology
|
2023-07 |
A TEAD2-driven endothelial-like program shapes basal-like differentiation and metastasis of pancreatic cancer |
Gastroenterology
|
2023-05 |
Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study |
Scientific Reports
|
2023-05 |
Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study |
The Journal of clinical endocrinology and metabolism
|
2023-03 |
Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis |
ADVANCED SCIENCE
|
2023-03 |
Enhanced Glutaminolysis Drives Hypoxia-Induced Chemoresistance in Pancreatic Cancer |
Cancer Research
|
2023-01 |
Covered versus uncovered double bare self-expandable metal stent for palliation of unresectable extrahepatic malignant biliary obstruction: a randomized controlled multicenter trial |
Gastrointestinal Endoscopy
|
2023-01 |
Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care |
Yonsei Medical Journal
|
2022-11 |
Redundant Electromagnetic Control of an Endoscopic Magnetic Capsule Driven by Multiple Electromagnets Configuration |
IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS
|
2022-11 |
Multifunctional microrobot with real-time visualization and magnetic resonance imaging for chemoembolization therapy of liver cancer |
Science advances
|
2022-11 |
A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma |
INTERNATIONAL JOURNAL OF CANCER
|
2022-10 |
Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection |
SCIENTIFIC REPORTS
|
2022-10 |
Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer |
Cancers
|
2022-09 |
Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial |
Cancers
|
2022-09 |
Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer |
Cancers
|
2022-06 |
Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9 |
RADIOLOGY
|
2022-04 |
Drug-Loaded Mucoadhesive Patch with Active Delivery and Controlled Releasing Ability |
ADVANCED INTELLIGENT SYSTEMS
|
2022-02 |
Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study |
Cancers
|
2022-02 |
Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
|
2022-01 |
Comparison of Clinical Performance and Safety between Domestic New Pull-type Triple-lumen Sphincterotome and Conventional Sphincterotome: A Prospective Multicenter Trial |
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|
2022-01 |
BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients |
Cancers
|
2022-01 |
Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis |
GUT AND LIVER
|
2021-11 |
Optimal drainage of anastomosis stricture after living donor liver transplantation |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
2021-10 |
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial |
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
|
2021-08 |
Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis |
SCIENTIFIC REPORTS
|
2021-08 |
Usefulness of Smartphone Applications for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial |
Journal of Medicine Internet Research Mhealth and Uhealth
|
2021-08 |
Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma |
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
|
2021-04 |
Serum Dickkopf-1 in Combined with CA 19-9 as a Biomarker of Intrahepatic Cholangiocarcinoma |
Cancers
|
2021-04 |
Comparison of high flow nasal oxygen and conventional nasal cannula during gastrointestinal endoscopic sedation in the prone position: a randomized trial |
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE
|
2021-03 |
Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer |
EBioMedicine
|
2021-02 |
Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population |
ACTA RADIOLOGICA
|
2021-02 |
Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2021-02 |
Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy |
ABDOMINAL RADIOLOGY
|
2021-01 |
Efficacy and safety of palliative endobiliary radiofrequency ablation using a novel temperature-controlled catheter for malignant biliary stricture: a single-center prospective randomized phase II TRIAL |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
2020-11 |
Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer |
PANCREAS
|
2020-07 |
Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? |
PANCREATOLOGY
|
2020-06 |
Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study |
Journal of Clinical Medicine
|
2020-04 |
FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study |
World Journal of Gastrointestinal Oncology
|
2020-04 |
Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
2020-03 |
Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
|
2020-02 |
A Variant of SLC1A5 is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells |
CELL METABOLISM
|
2020-01 |
Analysis of Clinical Predictive Factors Affecting the Outcome of 2nd Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer. |
GUT AND LIVER
|
2019-09 |
A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study |
PLOS ONE
|
2019-07 |
Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture |
CANCER MEDICINE
|
2019-05 |
Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma |
PANCREAS
|
2019-05 |
Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis |
YONSEI MEDICAL JOURNAL
|
2019-04 |
Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
2019-02 |
KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study |
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
|
2018-12 |
Multicenter phase Ⅱ trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer |
World Journal of Gastrointestinal Oncology
|
2018-11 |
Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer |
World Journal of Gastrointestinal Oncology
|
2018-10 |
Revision of bilateral self-expandable metallic stents placed using the stent-in-stent technique for malignant hilar biliary obstruction. |
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
|
2018-09 |
Clinical Outcomes of Bilateral Stent-in-Stent Placement Using Self-Expandable Metallic Stent for High-Grade Malignant Hilar Biliary Obstruction |
YONSEI MEDICAL JOURNAL
|
2018-05 |
Oncologic outcomes after radical surgery for periampullary cancer in octogenarians |
Korean Journal Of Hepato-Biliary-Pancreatic Surgery
|
2018-04 |
Safety and efficacy of early feeding based on clinical assessment at 4 hours after ERCP: a prospective randomized controlled trial |
GASTROINTESTINAL ENDOSCOPY
|
2018-02 |
Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer |
SCIENTIFIC REPORTS
|
2018-02 |
Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis |
PLOS ONE
|
2018-01 |
Clinical Value of Contrast-Enhanced Harmonic Endoscopic Ultrasonography in the Differential Diagnosis of Pancreatic and Gallbladder Masses. |
Clinical Endoscopy
|
2017-12 |
Risk factors associated with adverse events during endoscopic ultrasound-guided tissue sampling. |
PLOS ONE
|
2017-12 |
Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer “in a Korean” population: A single-center cohort study |
SEMINARS IN ONCOLOGY
|
2017-11 |
Combination Therapy with Capecitabine and Cisplatin as Second-Line Chemotherapy for Advanced Biliary Tract Cancer |
CHEMOTHERAPY
|
2017-10 |
Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
2017-09 |
Assessment of the Risk of Colorectal Cancer Survivors Developing a Second Primary Pancreatic Cancer. |
GUT AND LIVER
|
2017-08 |
A prospective randomized study for efficacy of an uncovered double bare metal stent compared to a single bare metal stent in malignant biliary obstruction |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
2017-06 |
Clinical characteristics of second primary pancreatic cancer |
PLOS ONE
|
2017-05 |
Benefit of neoadjuvant concurrent chemoradiotherapy locally advanced perihilar cholangiocarcinoma |
WORLD JOURNAL OF GASTROENTEROLOGY
|
2017-04 |
The Significance of the Prognostic Nutritional Index for All Stages of Pancreatic Cancer |
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
|
2017-01 |
Best options for preoperative biliary drainage in patients with Klatskin tumors |
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
|
2017-01 |
A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea. |
MEDICINE
|
2016-10 |
A pilot study of concurrent chemoradiotherapy with gemcitabine and cisplatin in patients with locally advanced biliary tract cancer |
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
2016-09 |
Concomiant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer |
YONSEI MEDICAL JOURNAL
|
2016-06 |
Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer |
PLOS ONE
|
2016-05 |
Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients |
MEDICINE
|
2016-05 |
Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses |
PLOS ONE
|
2016-04 |
Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existingdiabetes existingdiabetes mellitus type 2 |
DIGESTIVE AND LIVER DISEASE
|